Shanghai Institute of Materia Medica, Chinese Academy of Sciences;Shanghai Green Valley Pharmaceutical Co., Ltd.
发明人:
申请号：
EP14813825.8
公开号：
EP3012259A1
申请日:
2014.06.18
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
This invention provides a class of five-member-heterocycle fused pyridine compounds as shown below in Formula (X), pharmaceutically acceptable salts or pharmaceutically acceptable solvates thereof, a method of preducing the same, pharmaceutical compositions containing the compound, and use of the compounds in preparing medicament for preventing and/or treating diseases and tumours associated with abnormal protein tyrosine kinase.
